TFS Capital’s Pacira BioSciences PCRX Stock Holding History

TFS Capital’s Portfolio PCRX Stock Details PCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell
2017 Q2	$838K	Buy
2016 Q3	–	Sell
2016 Q2	$1.32M	Buy
2015 Q4	–	Sell
2015 Q3	$585K	Buy
2014 Q2	–	Sell
2014 Q1	$2.11M	Buy